Dr. Arancio is a cellular neurobiologist who has pioneered the mechanisms of synaptic dysfunction in Alzheimer’s disease. He is an associate professor of pathology and cell biology at Columbia University Medical Center and at the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain at Columbia University. Over the last 10 years, Dr. Arancio has raised over $25 million in grant funding and published more than 100 peer-reviewed scientific papers. Dr Arancio’s honors include the “G. Moruzzi Fellowship” (Georgetown University), the “Anna Villa Rusconi Foundation Prize” (Italy), the “INSERM Poste vert Fellowship” (France), the Edward N. and Della L. Thome Memorial Foundation Award (2010), the Margaret Cahn Research Award (2008), the American Health Assistance Foundation Centennial Award (2007) and the Zenith Award (2007). He also founded Citta Pharmaceuticals, a biotech company that develops small molecules to treat Alzheimer’s disease.